Dr. Ray Antonio Manneh Kopp

Especialidad: Médico, Oncólogo
País: Colombia

Cargo Actual

  • Director científico.
  • Director de investigación clínica.

Lugar de Trabajo

  • Sociedad de Oncología y Hematología del Cesar
  • Clínica Porto Azul


  • ACHO
  • ASCO
  • SEOM
  • SCU
  • Grupo de oncología Genitourinaria de Colombia.


  • Immune Checkpoint Inhibitor Combination Therapy versusSunitinib as First-Line Treatment for Favorable-IMDC-RiskAdvanced Renal Cell Carcinoma Patients: A Meta-Analysis ofRandomized Clinical Trials. Biomedicines 2022.
  • Review Curr Treat Options Oncol. 2022 May 1. High-DoseSomatostatin Analogs for the Treatment of NeuroendocrineNeoplasms: where are we Now? Teresa Alonso-Gordoa, RayManneh, Enrique Grande, Javier Molina-Cerrillo
  • Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America,” Prostate Cancer, vol. 2021.
  • Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries. JCO Glob Oncol 2021.
  • Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC). JCO Glob Oncol 2021
  • Complete response and renall carcinoma in the immunohterapy era: The paradox of good news. Cancer Treat Rev. 2021.
  • Impact of COVID-19 infection on patients with cancer: experience in a latin American country: The ACHOCC-19 Study. Oncologist 2021 Oct;26
  • Combination of statin/vitamin D and metastatic castration-resistant prostate cáncer (CRPC): a post hoc analysis of two randomized clinical trials. Clin Transl Oncol 2020.
  • Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab. Clin Transl Oncol 2019.
  • Circulating tumor cells as a biomarker of survival and response to radium-223 therapy: experience in a cohort of patients with metastatic castration-resistant prostate cacner. Clin Genitourin Cancer. 2018.
  • Urothelial cáncer proteomics provides both prognostic and functional information. Sci Rep. 2017.
  • Prognostic significance of venous thromboembolic events in disseminated germ cell cáncer patients. J Natl Cancer Inst. 2017
  • Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusión MRI predicts survival in recurrent glioblastoma treated with bevacizumab. Clin Transl Oncol 2017.
  • GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and por performance status. Clin Transl Oncol. 2016.
  • GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and por performance status. Clin Transl Oncol. 2016.
  • Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cáncer patients. Clin Transl Oncol 2013.

Categoria: Conferencistas Internacionales

Eventos de ASONCO